Table 4. Clinical characteristic of HP patients with controlled and uncontrolled BP.
| BP controlled (n=88) | BP uncontrolled (n=52) | P-value | |
|---|---|---|---|
| Age (yr) | 58.19±7.70 | 59.62± 6.51 | 0.266 |
| Male gender (n, %) | 32/88 (36.4%) | 26/52 (50.0%) | 0.114 |
| BMI (kg m−2) | 25.16±3.58 | 25.22±3.36 | 0.920 |
| Smoker (n, %) | 22/88 (25.0%) | 23/52(44.2%) | 0.019 |
| Manual labour (n, %) | 56/88 (63.6%) | 34/52(67.3%) | 0.835 |
| Education (n, %) | 0.357 | ||
| Primary school and below (n, %) | 7/88(8.0%) | 5/52 (9.6%) | |
| Middle school (n, %) | 29/88 (33.0%) | 17/52 (32.7%) | |
| High school (n, %) | 36/88 (40.9%) | 26/52 (50.0%) | |
| University and above (n, %) | 16/88 (18.2%) | 4/52 (7.7%) | |
| CAD (n, %) | 28/88 (31.8%) | 17/52 (32.3%) | 0.915 |
| DM (n, %) | 16/88 (18.2%) | 11/52 (21.2%) | 0.667 |
| Dyslipidemia (n, %) | 72/88 (81.8%) | 44/52 (84.6%) | 0.671 |
| Creatinine (μM) | 66.27±14.68 | 66.03±14.90 | 0.927 |
| CHOL(mM) | 4.73±1.14 | 4.77±0.95 | 0.850 |
| TG (mM) | 2.10±1.69 | 2.22±1.77 | 0.677 |
| LDL-c (mM) | 2.82±1.06 | 2.87±0.83 | 0.758 |
| HDL-c (mM) | 1.10±0.33 | 1.02±0.29 | 0.170 |
| HR before Ex (b.p.m.) | 79.82±12.13 | 82.77±12.24 | 0.168 |
| Peak HR (b.p.m.) | 140.84±7.40 | 139.81±6.78 | 0.412 |
| HR1 (b.p.m.) | 113.71±10.44 | 115.92±9.46 | 0.213 |
| HRR1 (b.p.m.) | 27.13±7.59 | 23.88±7.96 | 0.018 |
| HRR1 ⩽24 b.p.m. (%) | 33/88(37.5%) | 32/52(61.5%) | 0.006 |
| HR2 (b.p.m.) | 95.18±12.27 | 97.88±14.90 | 0.247 |
| HRR2 (b.p.m.) | 45.66±9.42 | 41.92±14.12 | 0.093 |
| HRR2 ⩽42 b.p.m. (%) | 37/88 (42.05%) | 26/52 (50.00%) | 0.361 |
| HR3 (b.p.m.) | 88.86±12.03 | 92.60±13.23 | 0.090 |
| HRR3 (b.p.m.) | 51.98±9.76 | 47.21±12.84 | 0.014 |
| HR4 (b.p.m.) | 86.51±10.97 | 89.52±13.09 | 0.147 |
| HRR4 (b.p.m.) | 54.33±9.10 | 50.29±12.89 | 0.050 |
| HR5 (b.p.m.) | 85.30±11.31 | 88.21±12.91 | 0.164 |
| HRR5 (b.p.m.) | 55.55±9.41 | 51.60±12.51 | 0.036 |
| SBP before Ex (mm Hg) | 121.80±8.60 | 145.21±9.09 | 0.000 |
| DBP before Ex (mm Hg) | 77.02±6.28 | 87.10±9.22 | 0.000 |
| SBP peak (mm Hg) | 164.55±16.22 | 181.26±20.07 | 0.026 |
| DBP peak (mm Hg) | 70.82±8.40 | 85.63±9.09 | 0.000 |
| SBP at 1 min post Ex (mm Hg) | 144.07±19.70 | 166.31±19.62 | 0.001 |
| DBP at 1 min post Ex (mm Hg) | 77.93±9.40 | 85.62±12.08 | 0.018 |
| SBP at 5 min post Ex (mm Hg) | 132.42±17.22 | 138.60±32.99 | 0.249 |
| DBP at 5 min post Ex (mm Hg) | 77.68±7.62 | 80.96±20.24 | 0.311 |
| Time for Ex (minute) | 4.30±1.69 | 4.14±1.77 | 0.598 |
| Exercise tolerance (Mets) | 6.49±1.76 | 6.16±1.78 | 0.286 |
| Ejection fraction | 0.63±0.07 | 0.62±0.07 | 0.279 |
| Medication | |||
| Aspirin use (n, %) | 53/88 (60.2%) | 37/52 (71.1%) | 0.192 |
| Statin use (n, %) | 59/88 (67.0%) | 39/52 (75.0%) | 0.321 |
| Bata-blockers use (n, %) | 46/88 (52.3%) | 24/52 (46.2%) | 0.484 |
| ACEI use (n, %) | 23/88 (26.1%) | 16/52 (30.8%) | 0.555 |
| ARBs use (n, %) | 23/88 (26.1%) | 18/52 (34.6%) | 0.287 |
| CCB use (n, %) | 53/88 (60.2%) | 40/52 (76.9%) | 0.043 |
| Diuretics use (n, %) | 7/88 (8.0%) | 5/52 (9.6%) | 0.979 |
| categories of drugs | 0.039 | ||
| Monotherapy (n, %) | 35/88 (39.8%) | 12/52 (23.1%) | |
| Two drug therapy (n, %) | 43/88 (48.9%) | 27/52 (51.9%) | |
| ⩾Three drug therapy (n, %) | 10/88 (11.4%) | 13/52 (25.0%) |
Abbreviations: ACEI, angiotensin-converting enzyme inhibitor; ARBs, angiotensin receptor blocker; BP, blood pressure; BMI, body mass index; CAD, coronary artery disease; CCB, calcium channel blocker; CHOL, cholesterol; DBP, diastolic blood pressure; DM, diabetes mellitus; Ex, treadmill exercise; HDL-c, high density lipoprotein cholesterol; HP, hypertensive; HR, heart rate; HRn, heart rate at n minute post exercise; HRR, heart rate recovery; HRRn, heart rate recovery at n minute post exercise; LDL-c, low density lipoprotein cholesterol; Mets, metabolic equivalents (1MET=3.5 ml kg−1 per minute of oxygen consumption); SBP, systolic blood pressure; TG, triglyceride; yr, year.